Bluejay Diagnostics (BJDX) Treasury Shares (2022 - 2025)

Bluejay Diagnostics' Treasury Shares history runs 4 years deep, the most recent figure standing at $1.0 for Q1 2025.

• In Q1 2025, Treasury Shares fell 99.9% year-over-year to $1.0; the TTM figure through Mar 2025 stood at $1.0 (down 99.9% YoY), while the FY2024 annual figure was $1.0, down 95.0% from the prior year.
• Treasury Shares came in at $1.0 for Q1 2025 at Bluejay Diagnostics, roughly flat from $1.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $197500.0 in Q1 2023 to a low of $1.0 in Q4 2024.
• A 4-year average of $33158.0 and a median of $2000.0 in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares tumbled 89.5% in 2023 and sank 99.9% in 2025, its largest moves.
• Bluejay Diagnostics' Treasury Shares stood at $3000.0 in 2022, then sank by 99.33% to $20.0 in 2023, then slumped by 95.0% to $1.0 in 2024, then changed by 0.0% to $1.0 in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $1.0, $1.0, and $62.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison